- 著者
- 村田 智 板井 悠二 朝戸 幹雄 小林 尚志 中島 光太郎 斎田 幸久 江口 信子 菅原 信二 倉本 賢明 ムラタ サトル イタイ ユウジ アサト ミキオ コバヤシ ヒサシ ナカジマ コウタロウ サイダ ユキヒサ エグチ ノブコ スガハラ シンジ クラモト ケンメイ Murata Satoru Itai Yuji Asato Mikio Kobayashi Hisashi Nakajima Kotaro Saida Yukihisa Eguchi Nobuko Sugahara Shinji Kuramoto Kenmei
- 出版者
- 日本医学放射線学会
- 雑誌
- 日本医学放射線学会雑誌 (ISSN:00480428)
- 巻号頁・発行日
- vol.55, no.3, pp.184-186, 1995-02-25
- 著者
- Oshiro Yoshiko Mizumoto Masashi Okumura Toshiyuki Sugahara Shinji Fukushima Takashi Ishikawa Hitoshi Nakao Tomohei Hashimoto Takayuki Tsuboi Koji Ohkawa Haruo Kaneko Michio Sakurai Hideyuki
- 出版者
- BioMed Central Ltd.
- 雑誌
- Radiation oncology (ISSN:1748717X)
- 巻号頁・発行日
- vol.8, pp.142, 2013-06
- 被引用文献数
- 33 2
PurposeTo evaluate the efficacy of proton beam therapy (PBT) for pediatric patients with advanced neuroblastoma.MethodsPBT was conducted at 21 sites in 14 patients with neuroblastoma from 1984 to 2010. Most patients were difficult to treat with photon radiotherapy. Two and 6 patients were classified into stages 3 and 4, respectively, and 6 patients had recurrent disease. Seven of the 8 patients who received PBT as the initial treatment were classified as the high risk group. Twelve patients had gross residual disease before PBT and 2 had undergone intraoperative radiotherapy before PBT. Five patients received PBT for multiple sites, including remote metastases. Photon radiotherapy was used in combination with PBT for 3 patients. The PBT doses ranged from 19.8 to 45.5 GyE (median: 30.6 GyE).ResultsSeven patients are alive with no evidence of disease, 1 is alive with disease progression, and 6 died due to the tumor. Recurrence in the treatment field was not observed and the 3-year locoregional control rate was 82%. Severe acute radiotoxicity was not observed, but 1 patient had narrowing of the aorta and asymptomatic vertebral compression fracture at 28 years after PBT, and hair loss was prolonged in one patient.ConclusionPBT may be a better alternative to photon radiotherapy for children with advanced neuroblastoma, and may be conducted safely for patients with neuroblastoma that is difficult to manage using photon beams.